Atlas FDA

Ranger™ Paclitaxel-Coated PTA Balloon Catheter

FDA premarket approval P190019/S038 · decided 2025-06-26

Approval details

PMA number
P190019
Supplement
S038
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Ranger™ Paclitaxel-Coated PTA Balloon Catheter
Generic name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Applicant
Boston Scientific Corporation
Date received
2025-03-21
Decision date
2025-06-26
Days to decision
97 days
Decision code
APPR
Product code
ONU
Advisory committee
Cardiovascular
Expedited review
No
Location
Maple Grove, MN
Statement
the addition of another manufacturing building and cleanroom at the same contract manufacturer facility to accommodate additional future drug coating lines

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27